We investigate if demand for branded prescription medications in post-patent markets is
patient-or doctor driven. When drugs go off-patent the brand medication often maintains non …

We study the short-and long-term price effects of the number of competing firms, using panel-
data on 1303 distinct pharmaceutical markets for 78 months within a reference-price system …

What has been the effect of competition from parallel imports on prices of locally sourced on-
patent drugs? Did the 2002 Swedish mandatory substitution reform increase this …

We use Swedish data on consumer choices of therapeutically equivalent drugs to measure
the zero-price effect. The Swedish benefit scheme for prescription drugs is a tier system …

This article shows how state dependence effects can be estimated for many markets and
with few assumptions by using data on how the shares of consumers buying specific …

This paper analyzes how allowing pharmacies to negotiate discounts with parallel traders
and producers affects the market share for parallel imports. Economic theory predicts that …

Background and objective Medical specialists have an essential role in promotion of generic
medicines. However, misconceptions and negative perceptions about generic medicines …

We analyze 319,000 choices of medically equivalent drugs at Swedish pharmacies. The
results show that patients dislike substitutions for the prescribed product and that this effect …

Prescription drugs are the third largest component of US healthcare expenditures. The 2006
Medicare Part D and the 2010 Affordable Care Act are catalysts for further growths in …

To identify the relevant product markets for Swedish pharmaceuticals, a spatial
econometrics approach is employed. First, we calculate Moran's Is for different market …